LumiraDx Ltd — Form D/A

LumiraDx Ltd of LONDON, X0, a company, filed a Form D amendment with the SEC on 2020-05-28. The offering totals $150.0M, of which $150.0M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Suresh VaziraniDirectorLondon, X0
Peter WelchExecutive OfficerLondon, X0
George NebleDirectorBoston, MA
Gerald ChanDirectorMonaco, O9
Ron ZwanzigerDirectorBOSTON, MA
Ron ZwanzigerExecutive OfficerBOSTON, MA
David ScottDirectorLos Angeles, CA
David ScottExecutive OfficerLos Angeles, CA
David WaltonExecutive OfficerMelbourne, FL
Dorian LeBlancExecutive OfficerLondon, X0
Donald BerwickDirectorLondon, X0
Bruce KeoghDirectorLondon, X0
Lurene JosephDirectorLondon, X0
Lu HuangDirectorLondon, X0
Troyen BrennanDirectorLondon, X0
Amit ThakkerDirectorLondon, X0
Jerry McAleerDirectorLondon, X0
Jerry McAleerExecutive OfficerLondon, X0
Nigel LindnerExecutive OfficerLondon, X0
Veronique AmeyeExecutive OfficerLondon, X0
Tom QuinlanExecutive OfficerLondon, X0
Peter ScheuExecutive OfficerLondon, X0
Sumit NagpalExecutive OfficerLondon, X0
Troy BrennanDirectorLondon, X0

Other filings by this issuer (10)

FiledFormOfferingSold
2020-12-15D$164.0M$164.0M
2020-04-21D/A$74.0M$52.5M
2020-04-17D$74.0M$52.5M
2020-04-03D$74.0M
2020-02-26D$150.0M$75.2M
2019-09-04D$76.7M$76.7M
2019-01-17D$300.0M$270.0M
2016-12-13D$613K$613K
2016-10-17D$42.6M$42.6M
2016-10-13D

More